Immuneering Corp Annual Net Cash Provided by (Used in) Operating Activities in USD from 2020 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Immuneering Corp quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2020 to 2023.
- Immuneering Corp Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$15.5M, a 7.44% decline year-over-year.
- Immuneering Corp annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$49M, a 11% decline from 2022.
- Immuneering Corp annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$44.1M, a 43% decline from 2021.
- Immuneering Corp annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$30.9M, a 111% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)